Alicia J. Hager Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Alicia J. Hager.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Alicia J. Hager. Alicia J. Hager is SVP & General Counsel in OncoMed Pharmaceuticals Inc ($OMED) and SVP and General Counsel in OncoMed Pharmaceuticals Inc ($OMED) and VP & General Counsel in OncoMed Pharmaceuticals Inc ($OMED) and Chief Legal Officer in Nkarta, Inc. ($NKTX).
Latest Insider Trading Transactions of Alicia J. Hager
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12 2021 | NKTX | Nkarta, Inc. | Hager Alicia J. | Chief Legal Officer | Option Exercise | A | 54.89 | 13,125 | 720,431 | 13,125 | |
| Oct 28 2020 | NKTX | Nkarta, Inc. | Hager Alicia J. | Chief Legal Officer | Option Exercise | A | 31.11 | 150,000 | 4,666,500 | 150,000 | |
| Apr 23 2019 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | SVP and General Cou ... | Sell | U | 0.00 | 39,488 | 0 | 0 | 39.5 K to 0 (-100.00 %) |
| Oct 11 2018 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | SVP & General Couns ... | Sell | S | 2.02 | 1,156 | 2,335 | 51,754 | 52.9 K to 51.8 K (-2.18 %) |
| Oct 10 2018 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | SVP & General Couns ... | Sell | S | 2.13 | 1,686 | 3,589 | 52,910 | 54.6 K to 52.9 K (-3.09 %) |
| Apr 26 2018 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | SVP & General Couns ... | Sell | S | 2.68 | 4,051 | 10,848 | 54,596 | 58.6 K to 54.6 K (-6.91 %) |
| Jan 08 2018 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | SVP & General Couns ... | Option Exercise | A | 3.98 | 70,000 | 278,600 | 70,000 | |
| Oct 12 2017 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | SVP & General Couns ... | Sell | S | 4.24 | 1,202 | 5,099 | 58,647 | 59.8 K to 58.6 K (-2.01 %) |
| Oct 12 2017 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | SVP & General Couns ... | Sell | S | 4.26 | 46 | 196 | 59,849 | 59.9 K to 59.8 K (-0.08 %) |
| Oct 10 2017 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | SVP & General Couns ... | Option Exercise | A | 4.36 | 36,666 | 159,864 | 36,666 | |
| Oct 10 2017 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | SVP & General Couns ... | Grant | A | 0.00 | 18,334 | 0 | 59,895 | 41.6 K to 59.9 K (+44.11 %) |
| Apr 25 2017 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | SVP & General Couns ... | Option Exercise | A | 3.73 | 60,000 | 223,800 | 60,000 | |
| Apr 25 2017 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | SVP & General Couns ... | Grant | A | 0.00 | 20,000 | 0 | 41,561 | 21.6 K to 41.6 K (+92.76 %) |
| Apr 05 2017 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | SVP & General Couns ... | Sell | S | 9.06 | 4,284 | 38,805 | 21,561 | 25.8 K to 21.6 K (-16.58 %) |
| Apr 05 2017 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | SVP & General Couns ... | Sell | S | 8.87 | 32 | 284 | 25,845 | 25.9 K to 25.8 K (-0.12 %) |
| Mar 17 2017 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | SVP & General Couns ... | Option Exercise | M | 3.42 | 6,652 | 22,750 | 0 | |
| Mar 17 2017 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | SVP & General Couns ... | Sell | S | 10.00 | 6,652 | 66,520 | 25,877 | 32.5 K to 25.9 K (-20.45 %) |
| Mar 17 2017 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | SVP & General Couns ... | Buy | M | 3.42 | 6,652 | 22,750 | 32,529 | 25.9 K to 32.5 K (+25.71 %) |
| Jan 05 2017 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | SVP & General Couns ... | Option Exercise | A | 7.66 | 55,000 | 421,300 | 55,000 | |
| Oct 11 2016 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Grant | A | 0.00 | 12,500 | 0 | 25,877 | 13.4 K to 25.9 K (+93.44 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Sell | S | 21.33 | 1 | 21 | 13,377 | 13.4 K to 13.4 K (-0.01 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Sell | S | 21.54 | 52 | 1,120 | 13,378 | 13.4 K to 13.4 K (-0.39 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Sell | S | 22.30 | 1,570 | 35,012 | 13,430 | 15 K to 13.4 K (-10.47 %) |
| Dec 29 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Option Exercise | A | 21.43 | 40,000 | 857,200 | 40,000 | |
| Dec 01 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Option Exercise | M | 3.42 | 1,800 | 6,156 | 6,652 | |
| Dec 01 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Sell | S | 23.14 | 1,800 | 41,654 | 15,000 | 16.8 K to 15 K (-10.71 %) |
| Dec 01 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Buy | M | 3.42 | 1,800 | 6,156 | 16,800 | 15 K to 16.8 K (+12.00 %) |
| Oct 29 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Option Exercise | M | 3.42 | 5,400 | 18,468 | 8,452 | |
| Oct 29 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Sell | S | 21.00 | 5,400 | 113,400 | 15,000 | 20.4 K to 15 K (-26.47 %) |
| Oct 29 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Buy | M | 3.42 | 5,400 | 18,468 | 20,400 | 15 K to 20.4 K (+36.00 %) |
| Jul 29 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Option Exercise | M | 3.42 | 1,800 | 6,156 | 13,852 | |
| Jul 29 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Sell | S | 21.00 | 1,800 | 37,800 | 15,000 | 16.8 K to 15 K (-10.71 %) |
| Jul 29 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Buy | M | 3.42 | 1,800 | 6,156 | 16,800 | 15 K to 16.8 K (+12.00 %) |
| Jun 30 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Option Exercise | M | 3.42 | 1,800 | 6,156 | 15,652 | |
| Jun 30 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Sell | S | 22.67 | 1,800 | 40,798 | 15,000 | 16.8 K to 15 K (-10.71 %) |
| Jun 30 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Buy | M | 3.42 | 1,800 | 6,156 | 16,800 | 15 K to 16.8 K (+12.00 %) |
| May 28 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Option Exercise | M | 3.42 | 1,800 | 6,156 | 17,452 | |
| May 28 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Sell | S | 23.07 | 1,800 | 41,527 | 15,000 | 16.8 K to 15 K (-10.71 %) |
| May 28 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Buy | M | 3.42 | 1,800 | 6,156 | 16,800 | 15 K to 16.8 K (+12.00 %) |
| Apr 29 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Option Exercise | M | 3.42 | 1,800 | 6,156 | 19,252 | |
| Apr 29 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Sell | S | 26.19 | 855 | 22,392 | 15,000 | 15.9 K to 15 K (-5.39 %) |
| Apr 29 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Sell | S | 25.16 | 945 | 23,780 | 15,855 | 16.8 K to 15.9 K (-5.62 %) |
| Apr 29 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Buy | M | 3.42 | 1,800 | 6,156 | 16,800 | 15 K to 16.8 K (+12.00 %) |
| Dec 22 2014 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Option Exercise | A | 21.18 | 35,000 | 741,300 | 35,000 | |
| Mar 27 2014 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
| Jul 19 2013 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Option Exercise | A | 17.00 | 10,000 | 170,000 | 10,000 |
Page: 1